Evidence-based guidelines for supportive care of patients with Ebola virus disease

The Lancet

Volumn 391, Issue 10121, 2018, Pages 700-708

  Lamontagne, François ^a,b   Fowler, Robert A ^c,d   Adhikari, Neill K ^c,d   Murthy, Srinivas ^e   Brett Major, David M ^f   Jacobs, Michael ^g   Uyeki, Timothy M ^h   Vallenas, Constanza ⁱ   Norris, Susan L ⁱ   Fischer, William A ^j   Fletcher, Thomas E ^k   Levine, Adam C ^l,m   Reed, Paul ^n,o   Bausch, Daniel G ^i,p   Gove, Sandy ^r   Hall, Andrew ^q   Shepherd, Susan ^s   Siemieniuk, Reed A ^t   Lamah, Marie Claude ^u   Kamara, Rashida ^v   Nakyeyune, Phiona ^w   Soka, Moses J ^x   Edwin, Ama ^y,z   Hazzan, Afeez A ^t,aa   Jacob, Shevin T ^ab   Elkarsany, Mubarak Mustafa ^ac   Adachi, Takuya ^ad   Benhadj, Lynda ^a,ah   Clément, Christophe ^ae   Crozier, Ian ^af   Garcia, Armando ^u   Hoffman, Steven J ^t,ag   Guyatt, Gordon H ^t   more..

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d Canada   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^g ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

ⁱ WORLD HEALTH ORGANIZATION   (Switzerland)

^j UNIVERSITY OF NORTH CAROLINA   (United States)

^k LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^l INTERNATIONAL MEDICAL CORPS   (United States)

^m BROWN UNIVERSITY   (United States)

ⁿ UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^o U S PUBLIC HEALTH SERVICE   (United States)

^p TULANE UNIVERSITY   (United States)

^q Centre for Telecommunications Research   (United Kingdom)

^r Integrated Management of Adolescent and Adult Illness Integrated Management of Childhood Illness) Alliance   (United States)

^s Alliance for International Medical Action   (Senegal)

^t MCMASTER UNIVERSITY   (Canada)

^u MÉDECINS SANS FRONTIÈRES   (Switzerland)

^v Ministry of Health and Sanitation   (Sierra Leone)

^w LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^x Ministry of Health   (Liberia)

^y KORLE BU TEACHING HOSPITAL   (Ghana)

^z GHANA HEALTH SERVICE   (Ghana)

^aa STATE UNIVERSITY OF NEW YORK   (United States)

^ab UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^ac KARARY UNIVERSITY   (Sudan)

^ad Toshima Tokyo Metropolitan Hospital   (Japan)

^ae Polyclinique Bordeaux Nord Aquitaine   (France)

^af MAKERERE UNIVERSITY   (Uganda)

^ag Dahdaleh Building 2120   (Canada)

^ah HÔPITAL CHARLES LEMOYNE   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; MORPHINE; NARCOTIC ANALGESIC AGENT; PLACEBO;

AFRICA; ANALGESIA; ANTIBIOTIC RESISTANCE; ARTICLE; CHOLERA; CLOSTRIDIUM DIFFICILE INFECTION; DISTRESS SYNDROME; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; EPIDEMIC; FAMILY; FATALITY; FRIEND; GASTROINTESTINAL DISEASE; HIGH INCOME COUNTRY; HUMAN; HYPOVOLEMIA; HYPOVOLEMIC SHOCK; INTERPERSONAL COMMUNICATION; LOW INCOME COUNTRY; MEDICAL CARE; MONITORING; MORTALITY; NONHUMAN; ORAL REHYDRATION THERAPY; PAIN; PRACTICE GUIDELINE; PRIORITY JOURNAL; VIRUS TRANSMISSION; VITAL SIGN; DISEASE MANAGEMENT; EVIDENCE BASED MEDICINE; HEALTH CARE FACILITY; HOSPITALIZATION; PATIENT ATTITUDE; PHYSIOLOGIC MONITORING; PROCEDURES; PSYCHOLOGY;

AFRICA, WESTERN; DISEASE MANAGEMENT; DISEASE OUTBREAKS; EVIDENCE-BASED MEDICINE; HEALTH FACILITIES; HEMORRHAGIC FEVER, EBOLA; HOSPITALIZATION; HUMANS; MONITORING, PHYSIOLOGIC; PAIN MANAGEMENT; PATIENT ACCEPTANCE OF HEALTH CARE; PRACTICE GUIDELINES AS TOPIC;

EID: 85031751000     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(17)31795-6     Document Type: Article

References (69)

1. Fowler, RA, Fletcher, T, Fischer, WA 2nd, et al. Caring for critically ill patients with ebola virus disease. Perspectives from west Africa. Am J Respir Crit Care Med 190 (2014), 733–737.
2. Lamontagne, F, Clement, C, Fletcher, T, Jacob, ST, Fischer, WA 2nd, Fowler, RA, Doing today's work superbly well–treating Ebola with current tools. N Engl J Med 371 (2014), 1565–1566.
3. Brett-Major, DM, Jacob, ST, Jacquerioz, FA, et al. Being ready to treat Ebola virus disease patients. Am J Trop Med Hyg 92 (2015), 233–237.
4. Leligdowicz, A, Fischer, WA 2nd, Uyeki, TM, et al. Ebola virus disease and critical illness. Crit Care, 20, 2016, 217.
5. Murthy, S, Ebola Clinical Care authors group. Ebola and provision of critical care. Lancet 385 (2015), 1392–1393.
6. Agua-Aqum, J, Allegranzi, B, Ariyarajah, A, et al. After Ebola in west Africa—unpredictable risks, preventable epidemics. N Engl J Med 375 (2016), 587–596.
7. Garske, T, Cori, A, Ariyarajah, A, et al. Heterogeneities in the case fatality ratio in the west African Ebola outbreak 2013–2016. Philos Trans R Soc Lond B Biol Sci, 372, 2017, 20160308.
8. Guyatt, G, Oxman, AD, Akl, EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64 (2011), 383–394.
9. Andrews, J, Guyatt, G, Oxman, AD, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 66 (2013), 719–725.
10. Balshem, H, Helfand, M, Schunemann, HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64 (2011), 401–406.
11. Guyatt, GH, Oxman, AD, Vist, G, et al. GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias). J Clin Epidemiol 64 (2011), 407–415.
12. Guyatt, GH, Oxman, AD, Kunz, R, et al. GRADE guidelines 6. Rating the quality of evidence—imprecision. J Clin Epidemiol 64 (2011), 1283–1293.
13. Guyatt, GH, Oxman, AD, Kunz, R, et al. GRADE guidelines: 7. Rating the quality of evidence—inconsistency. J Clin Epidemiol 64 (2011), 1294–1302.
14. Guyatt, GH, Oxman, AD, Kunz, R, et al. GRADE guidelines: 8. Rating the quality of evidence—indirectness. J Clin Epidemiol 64 (2011), 1303–1310.
15. Guyatt, GH, Oxman, AD, Montori, V, et al. GRADE guidelines: 5. Rating the quality of evidence—publication bias. J Clin Epidemiol 64 (2011), 1277–1282.
16. Stevens, W, Observations on the nature and the treatment of the Asiatic cholera, 1853, Hippolyte Bailliere, New York.
17. Mahalanabis, D, Choudhuri, AB, Bagchi, NG, Bhattacharya, AK, Simpson, TW, Oral fluid therapy of cholera among Bangladesh refugees. Johns Hopkins Med J 132 (1973), 197–205.
18. US Centers for Disease Control. Review of human-to-human transmission of Ebola virus, 2015, CDC, Atlanta.
19. WHO. Health worker Ebola infections in Guinea, Liberia, and Sierra Leone, 2014, World Health Organization, Geneva.
20. Hageman, JC, Hazim, C, Wilson, K, et al. Infection prevention and control for Ebola in health care settings—west Africa and United States. MMWR Suppl 65 (2016), 50–56.
21. Wamala, JF, Lukwago, L, Malimbo, M, et al. Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007–2008. Emerg Infect Dis 16 (2010), 1087–1092.
22. Richards, GA, Murphy, S, Jobson, R, et al. Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects. Crit Care Med 28 (2000), 240–244.
23. Uyeki, TM, Mehta, AK, Davey, RT Jr, et al. Clinical management of Ebola virus disease in the United States and Europe. N Engl J Med 374 (2016), 636–646.
24. Ansumana, R, Jacobsen, KH, Sahr, F, et al. Ebola in Freetown area, Sierra Leone—a case study of 581 patients. N Engl J Med 372 (2015), 587–588.
25. Guimard, Y, Bwaka, MA, Colebunders, R, et al. Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 179:suppl 1 (1999), S268–S273.
26. Moore, FA, McKinley, BA, Moore, EE, The next generation in shock resuscitation. Lancet 363 (2004), 1988–1996.
27. Carpenter, CC, Mitra, PP, Sack, RB, Dans, PE, Wells, SA, Chaudhuri, RN, Clinical evaluation of fluid requirements in Asiatic cholera. Lancet 1 (1965), 726–727.
28. Cardo, DM, Culver, DH, Ciesielski, CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med 337 (1997), 1485–1490.
29. Trim, JC, Elliott, TS, A review of sharps injuries and preventative strategies. J Hosp Infect 53 (2003), 237–242.
30. Cotte, J, Cordier, PY, Bordes, J, et al. Fluid resuscitation in Ebola virus disease: a comparison of peripheral and central venous accesses. Anaesth Crit Care Pain Med 34 (2015), 317–320.
31. Rees, PS, Lamb, LE, Nicholson-Roberts, TC, et al. Safety and feasibility of a strategy of early central venous catheter insertion in a deployed UK military Ebola virus disease treatment unit. Intensive Care Med 41 (2015), 735–743.
32. Ker, K, Tansley, G, Beecher, D, et al. Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease. Cochrane Database Syst Rev, 2, 2015 CD011386.
33. Maitland, K, Kiguli, S, Opoka, RO, et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med 364 (2011), 2483–2495.
34. McGee, S, Abernethy, WB 3rd, Simel, DL, The rational clinical examination. Is this patient hypovolemic?. JAMA 281 (1999), 1022–1029.
35. Steiner, MJ, DeWalt, DA, Byerley, JS, Is this child dehydrated?. JAMA 291 (2004), 2746–2754.
36. Levine, AC, Glavis-Bloom, J, Modi, P, et al. External validation of the DHAKA score and comparison with the current IMCI algorithm for the assessment of dehydration in children with diarrhoea: a prospective cohort study. Lancet Glob Health 4 (2016), e744–e751.
37. Hillman, K, Chen, J, Cretikos, M, et al. Introduction of the medical emergency team (MET) system: a cluster-randomised controlled trial. Lancet 365 (2005), 2091–2097.
38. McGaughey, J, Alderdice, F, Fowler, R, Kapila, A, Mayhew, A, Moutray, M, Outreach and early warning systems (EWS) for the prevention of intensive care admission and death of critically ill adult patients on general hospital wards. Cochrane Database Syst Rev, 3, 2007 CD005529.
39. Priestley, G, Watson, W, Rashidian, A, et al. Introducing Critical Care Outreach: a ward-randomised trial of phased introduction in a general hospital. Intensive Care Med 30 (2004), 1398–1404.
40. McNeill, G, Bryden, D, Do either early warning systems or emergency response teams improve hospital patient survival? A systematic review. Resuscitation 84 (2013), 1652–1667.
41. Parshuram, CS, Duncan, HP, Joffe, AR, et al. Multicentre validation of the bedside paediatric early warning system score: a severity of illness score to detect evolving critical illness in hospitalised children. Crit Care, 15, 2011, R184.
42. Hjortrup, PB, Haase, N, Bundgaard, H, et al. Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med 42 (2016), 1695–1705.
43. Marik, PE, Linde-Zwirble, WT, Bittner, EA, Sahatjian, J, Hansell, D, Fluid administration in severe sepsis and septic shock, patterns and outcomes: an analysis of a large national database. Intensive Care Med 43 (2017), 625–632.
44. NICE. Intravenous fluid therapy: intravenous fluid therapy in adults in hospital, 2013, National Institute for Health and Care Excellence, London.
45. Rhodes, A, Evans, LE, Alhazzani, W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43 (2017), 304–377.
46. Hunt, L, Gupta-Wright, A, Simms, V, et al. Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study. Lancet Infect Dis 15 (2015), 1292–1299.
47. Maciel, AT, Park, M, Differences in acid-base behavior between intensive care unit survivors and nonsurvivors using both a physicochemical and a standard base excess approach: a prospective, observational study. J Crit Care 24 (2009), 477–483.
48. Islam, SS, Khan, MU, Risk factors for diarrhoeal deaths: a case-control study at a diarrhoeal disease hospital in Bangladesh. Int J Epidemiol 15 (1986), 116–121.
49. Siegel, D, Hulley, SB, Black, DM, et al. Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. JAMA 267 (1992), 1083–1089.
50. Juurlink, DN, Mamdani, MM, Lee, DS, et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 351 (2004), 543–551.
51. Fisch, C, Relation of electrolyte disturbances to cardiac arrhythmias. Circulation 47 (1973), 408–419.
52. Kane, RL, Shamliyan, TA, Mueller, C, Duval, S, Wilt, TJ, The association of registered nurse staffing levels and patient outcomes: systematic review and meta-analysis. Med Care 45 (2007), 1195–1204.
53. Steinhubl, SR, Feye, D, Levine, AC, Conkright, C, Wegerich, SW, Conkright, G, Validation of a portable, deployable system for continuous vital sign monitoring using a multiparametric wearable sensor and personalised analytics in an Ebola treatment centre. BMJ Glob Health, 1, 2016, e000070.
54. Abad, C, Fearday, A, Safdar, N, Adverse effects of isolation in hospitalised patients: a systematic review. J Hosp Infect 76 (2010), 97–102.
55. ACAPS. Ebola in west Africa. Guinea: resistance to the Ebola response. https://www.acaps.org/sites/acaps/files/products/files/h_guinea_resistance_to_the_ebola_response_24_april_2015.pdf, 2015 (accessed June 13, 2017).
56. Nielsen, CF, Kidd, S, Sillah, AR, et al. Improving burial practices and cemetery management during an Ebola virus disease epidemic—Sierra Leone, 2014. MMWR Morb Mortal Wkly Rep 64 (2015), 20–27.
57. Zeppetella, G, Davies, A, Eijgelshoven, I, Jansen, JP, A network meta-analysis of the efficacy of opioid analgesics for the management of breakthrough cancer pain episodes. J Pain Symptom Manage 47 (2014), 772–785.
58. Aubrun, F, Mazoit, JX, Riou, B, Postoperative intravenous morphine titration. Br J Anaesth 108 (2012), 193–201.
59. Berterame, S, Erthal, J, Thomas, J, et al. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet 387 (2016), 1644–1656.
60. Gaisford, WF, Results of the treatment of 400 cases of lobar pneumonia with M & B 693: (Section of Medicine). Proc R Soc Med 32 (1939), 1070–1076.
61. Plummer, N, Ensworth, H, Preliminary report of the use of sulfapyridine in the treatment of pneumonia. Bull NY Acad Med 15 (1939), 241–248.
62. Loo, VG, Bourgault, AM, Poirier, L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 365 (2011), 1693–1703.
63. Brown, K, Valenta, K, Fisman, D, Simor, A, Daneman, N, Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection. JAMA Intern Med 175 (2015), 626–633.
64. Daneman, N, Bronskill, SE, Gruneir, A, et al. Variability in antibiotic use across nursing homes and the risk of antibiotic-related adverse outcomes for individual residents. JAMA Intern Med 175 (2015), 1331–1339.
65. WHO. Guidelines for the treatment of malaria, 3rd edn., 2015, World Health Organization, Geneva.
66. Kreuels, B, Wichmann, D, Emmerich, P, et al. A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med 371 (2014), 2394–2401.
67. Lamb, L, Robson, J, Ardley, C, et al. Bacterial co-infection is rare in patients with Ebola virus disease in a military Ebola virus disease treatment unit in Sierra Leone. J Infect 71 (2015), 406–407.
68. Reddy, EA, Shaw, AV, Crump, JA, Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect Dis 10 (2010), 417–432.
69. Boozary, AS, Farmer, PE, Jha, AK, The Ebola outbreak, fragile health systems, and quality as a cure. JAMA 312 (2014), 1859–1860.